Submit Manuscript    >>    Login | Register

Advances in Electrophysiology


Hope this edition of JAFIB finds you in good health and better spirits. Congratulations to Jeremy Ruskin and team on yet another successfully organized Atrial Fibrillation Symposium in Orlando. The focus this year seems to be on stroke prevention, left atrial appendage and therapies for non-paroxysmal AF. The interim results of REAFFIRM trial have been presented. It was not surprising to see that there was no difference between the FIRM ablation group compared to the control which did very well compared to any other historical groups in similar persistent AF studies. The lesion set used in these patients is not properly controlled and is mostly left to the operator discretion. Results from the long-term will be interesting to watch even though it will come at significant costs

Credits: Dhanunjaya Lakkireddy



Biosense Webster
event date
Introduction to AFib
Ablation Specialist

View Ablation Specialists